A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs

References

• Lee CJ, Huang YC, Yang S, et al. Clinical features of coxsackievirus A4, B3 and B4 infections in children. PLoS One. 2014;9(2):e87391. doi: 10.1371/journal.pone.0087391
   PubMed Web of Science ®Google Scholar
• Upala P, Apidechkul T, Suttana W, et al. Molecular epidemiology and clinical features of hand, foot and mouth disease in northern Thailand in 2016: a prospective cohort study. BMC Infect Dis. 2018;18(1):630. doi: 10.1186/s12879-018-3560-4
   PubMed Web of Science ®Google Scholar
• Gao L, Zou G, Liao Q, et al. Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples. Clin Infect Dis. 2018;67(11):1729–1735. doi: 10.1093/cid/ciy341
   PubMed Web of Science ®Google Scholar
• Weng Y, Chen W, He W, et al. Serotyping and genetic characterization of hand, foot, and mouth disease (HFMD)-associated enteroviruses of no-EV71 and non-CVA16 Circulating in Fujian, China, 2011-2015. Med Sci Monit. 2017;23:2508–2518. doi: 10.12659/MSM.901364
   PubMed Web of Science ®Google Scholar
• Guan H, Wang J, Wang C, et al. Etiology of multiple non-EV71 and Non-CVA16 enteroviruses associated with hand, foot and mouth disease in Jinan, China, 2009-June 2013. PLoS One. 2015;10(11):e0142733. doi: 10.1371/journal.pone.0142733
   PubMed Web of Science ®Google Scholar
• Wang M, Li J, Yao MX, et al. Genome analysis of coxsackievirus A4 isolates from hand, foot, and mouth disease cases in Shandong, China. Front Microbiol. 2019;10:1001. doi: 10.3389/fmicb.2019.01001
   PubMed Web of Science ®Google Scholar
• Li J, Yang Z, Wang Z, et al. The surveillance of the epidemiological and serotype characteristics of hand, foot, mouth disease in Neijiang city, China, 2010-2017: A retrospective study. PLoS One. 2019;14(6):e0217474. doi: 10.1371/journal.pone.0217474
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang H, Liu H, et al. Molecular characteristics of hand, foot, and mouth disease for hospitalized pediatric patients in Yunnan. China. Medicine (Baltimore. 2018;97(31):e11610. doi: 10.1097/MD.0000000000011610
   PubMed Web of Science ®Google Scholar
• Ji H, Fan H, Lu PX, et al. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infect Dis. 2019;19(1):79. doi: 10.1186/s12879-018-3659-7
   PubMed Web of Science ®Google Scholar
• Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS One. 2014;9(6):e98888. doi: 10.1371/journal.pone.0098888
   PubMed Web of Science ®Google Scholar
• Cobbin JCA, Britton PN, Burrell R, et al. A complex mosaic of enteroviruses shapes community-acquired hand, foot and mouth disease transmission and evolution within a single hospital. Virus Evol. 2018;4(2):vey020. doi: 10.1093/ve/vey020
   PubMed Web of Science ®Google Scholar
• Drago F, Ciccarese G, Gariazzo L, et al. Acute localized exanthem due to coxsackievirus A4. Infez Med. 2017;25(3):274–276.
   PubMedGoogle Scholar
• Lau SKP, Zhao PSH, Sridhar S, et al. Molecular epidemiology of coxsackievirus A6 circulating in Hong Kong reveals common neurological manifestations and emergence of novel recombinant groups. J Clin Virol. 2018;108:43–49. doi: 10.1016/j.jcv.2018.09.002
   PubMed Web of Science ®Google Scholar
• Akuzawa N, Harada N, Hatori T, et al. Myocarditis, hepatitis, and pancreatitis in a patient with coxsackievirus A4 infection: a case report. Virol J. 2014;11:3. doi: 10.1186/1743-422X-11-3
   PubMed Web of Science ®Google Scholar
• Palacios G, Oberste MS. Enteroviruses as agents of emerging infectious diseases. J Neurovirol. 2005;11:424–433. doi: 10.1080/13550280591002531
   PubMed Web of Science ®Google Scholar
• Li JS, Dong XG, Qin M, et al. Outbreak of febrile illness caused by coxsackievirus A4 in a nursery school in Beijing, China. Virol J. 2015;12:92. doi: 10.1186/s12985-015-0325-1
   PubMed Web of Science ®Google Scholar
• Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14(12):e1076–e1081. doi: 10.1016/j.ijid.2010.07.006
   PubMed Web of Science ®Google Scholar
• Chen P, Wang H, Tao Z, et al. Multiple transmission chains of coxsackievirus A4 co-circulating in China and neighboring countries in recent years: phylogenetic and spatiotemporal analyses based on virological surveillance. Mol Phylogenet Evol. 2018;118:23–31. doi: 10.1016/j.ympev.2017.09.014
   PubMed Web of Science ®Google Scholar
• Wu KX, Ng MM, Chu JJ. Developments towards antiviral therapies against enterovirus 71. Drug Discov Today. 2010;15:1041–1051. doi: 10.1016/j.drudis.2010.10.008
   PubMed Web of Science ®Google Scholar
• Li ZH, Li CM, Ling P, et al. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis. 2008;197:854–857. doi: 10.1086/527326
   PubMed Web of Science ®Google Scholar
• Zeng M, Zheng X, Wei R, et al. The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis. 2013;7:e2599. doi: 10.1371/journal.pntd.0002599
   PubMed Web of Science ®Google Scholar
• Wu J, Cheng YB, Li ZF, et al. Evaluation of adrenocortical function in children with severe and critical enterovirus 71 infection. Chin J Pediatr. 2012;50:249–254.
   Google Scholar
• Schimmer BP, Parker KL. Chapter 59: Adrenocorticotropic hormones; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill; 1996. p. 1459–1485.
   Google Scholar
• Rafique G, Bukhsh A, Gul A, et al. Hematologic adverse effects and efficacy monitoring in chronic Hepatitis C patients treated with interferon and ribavirin combination therapy. Pak J Pharm Sci. 2017;30(1):11–16.
   PubMed Web of Science ®Google Scholar
• Huang LM, Chiu CH, Chiu NC, et al. Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan. Vaccine. 2019;37(13):1827–1835. doi: 10.1016/j.vaccine.2019.02.023
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liang Z, Zeng J, et al. Immunogenicity and safety of an inactivated enterovirus 71 vaccine administered simultaneously with recombinant hepatitis B vaccine and group A meningococcal polysaccharide vaccine: a phase IV, open-label, single-center, randomized, non-inferiority trial. J Infect Dis. 2019;220(3):392–399. doi: 10.1093/infdis/jiz129
   PubMed Web of Science ®Google Scholar
• Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. New Engl J Med. 2014;370(9):818–828. doi: 10.1056/NEJMoa1304923
   PubMed Web of Science ®Google Scholar
• Li JX, Song YF, Wang L, et al. Two-year efficacy and immunogenicity of Sinovac enterovirus 71 vaccine against hand, foot and mouth disease in children. Expert Rev Vaccines. 2016;15(1):129–137. doi: 10.1586/14760584.2016.1096782
   PubMed Web of Science ®Google Scholar
• Hu Y, Zeng G, Chu K, et al. Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: a further observation. Hum Vaccin Immunother. 2018;26:1–5. doi: 10.1080/21645515.2018.1486154
   Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating 50 percent end-points. Am J Epidemiol. 1938;27:493–497. doi: 10.1093/oxfordjournals.aje.a118408
   Google Scholar
• Zhang Z, Dong Z, Wei Q, et al. A neonatal murine model of coxsackievirus A6 infection for evaluation of antiviral and vaccine efficacy. J Virol. 2017;91(9):e02450–16. doi: 10.1128/JVI.02450-16
   PubMed Web of Science ®Google Scholar
• D’Ugo E, Marcheggiani S, Fioramonti I, et al. Detection of human enteric viruses in freshwater from European countries. Food Environ Virol. 2016;8:206–214. doi: 10.1007/s12560-016-9238-4
   PubMed Web of Science ®Google Scholar
• Ong KC, Devi S, Cardosa MJ, et al. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol. 2010;84(1):661–665. doi: 10.1128/JVI.00999-09
   PubMed Web of Science ®Google Scholar
• Khong WX, Yan B, Yeo H, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012;86(4):2121–2131. doi: 10.1128/JVI.06103-11
   PubMed Web of Science ®Google Scholar
• Liu L, Zhao H, Zhang Y, et al. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology. 2011;412(1):91–100. doi: 10.1016/j.virol.2010.12.058
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang L, Liao Y, et al. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. Vaccine. 2015;33(46):6290–6297. doi: 10.1016/j.vaccine.2015.09.047
   PubMed Web of Science ®Google Scholar
• Mao Q, Wang Y, Gao R, et al. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol. 2012;86:11967–11976. doi: 10.1128/JVI.00902-12
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dong Z, Li J, et al. Protective efficacy of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection. J Virol. 2017;91(13):e00333–17. doi: 10.1128/JVI.00333-17
   PubMed Web of Science ®Google Scholar
• Du Z, Zhao Y, Luo Y, et al. Ongoing change of severe hand, foot, and mouth disease pathogens in Yunnan, China, 2012 to 2016. J Med Virol. 2019;91(5):881–885. doi: 10.1002/jmv.25393
   PubMed Web of Science ®Google Scholar
• Ye N, Gong X, Pang LL, et al. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis. 2015;15:225. doi: 10.1186/s12879-015-0965-1
   PubMed Web of Science ®Google Scholar
• Chen Z, Li R, Xie Z, et al. IL-6. IL; 10, and IL-13 are associated with pathogenesis in children with enterovirus 71 infection. Int J Clin Exp Med. 2014;7:2718–2723.
   PubMed Web of Science ®Google Scholar
• Wang SM, Lei HY, YUu CK, et al. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis. 2008;198(7):1002–1006. doi: 10.1086/591462
   PubMed Web of Science ®Google Scholar
• Wang SM, Lei HY, Su LY, et al. Cerebrospinal fluid and cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. Clin Microbiol Infect. 2007;13:677–682. doi: 10.1111/j.1469-0691.2007.01729.x
   PubMed Web of Science ®Google Scholar
• Lin TY, Hsia SH, Huang YC, et al. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis. 2003;36:269–274. doi: 10.1086/345905
   PubMed Web of Science ®Google Scholar
• Khong WX, Foo DG, Trasti SL, et al. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol. 2011;85:3067–3076. doi: 10.1128/JVI.01779-10
   PubMed Web of Science ®Google Scholar
• Wang SM, Lei HY, Huang MC, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37:47–52. doi: 10.1016/j.jcv.2006.05.009
   PubMed Web of Science ®Google Scholar
• Papa A, Dumaidi K, Franzidou F, et al. Genetic variation of coxsackievirus B5 strains associated with aseptic meningitis in Greece. Clin Microbiol Infect. 2006;12:688–691. doi: 10.1111/j.1469-0691.2006.01476.x
   PubMed Web of Science ®Google Scholar
• Graci JD, Gnädig NF, Galarraga JE, et al. Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis. J Virol. 2012;86(5):2869–2873. doi: 10.1128/JVI.05712-11
   PubMed Web of Science ®Google Scholar
• Huang X, Zhang X, Wang F, et al. Clinical efficacy of therapy with recombinant human interferon α1b in hand, foot, and mouth disease with enterovirus 71 infection. PLoS One. 2016;11:e0148907. doi: 10.1371/journal.pone.0148907
   PubMed Web of Science ®Google Scholar
• Wang SM, Lei HY, Liu CC. Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol. 2012;2012:876241.
   PubMedGoogle Scholar
• Fu C, Lu L, Wu H, et al. Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies. Sci Rep. 2016;6:38874. doi: 10.1038/srep38874
   PubMed Web of Science ®Google Scholar
• Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14(4):308-318. doi: 10.1016/S1473-3099(13)70342-6
   PubMed Web of Science ®Google Scholar